Abus médicamenteux et céphalées chroniques à Brazzaville: profil et parcours thérapeutique des patients
| Autor: | Edgard Matali, Dominique Nguiegna, Karen Obondzo-Aloba, Julien Arzur, Dieudonné Gnonlonfoun, Komi Assogba, Franck Ladys Banzouzi, Paul Macaire Ossou-Nguiet |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male Pediatrics medicine.medical_specialty Longitudinal study Neurology Adolescent Headache Disorders Medication-overuse Abus médicamenteux Young Adult Risk Factors Brazzaville headaches medicine Headache Disorders Secondary Humans Longitudinal Studies Young adult céphalées Aged business.industry Research Age Factors General Medicine Middle Aged Protective Factors Congo Concomitant Ambulatory Population study Educational Status International Classification of Headache Disorders Female Headaches medicine.symptom business |
| Zdroj: | The Pan African Medical Journal |
| ISSN: | 1937-8688 |
| Popis: | Introduction Medication-overuse headaches (MOHs) are the least studied of all headaches in Africa. Methods We conducted a longitudinal study in order to describe our experience with patients placed in Neurology Outpatient observation in Brazzaville over a period of 4 years, from September 2010 to August 2014. All patients with chronic primary headaches, according to the International Classification of Headache Disorders (ICHD) (2nd edition), were included in the study. All patient with secondary headaches or who hadn't given consent were excluded. The patients were divided into two groups: those who had progressed to medication-overuse and those who didn't meet the criteria for medication-overuse (without-MOH). The variables used were the sociodemographic characteristics of patients, the clinical features of primary headaches and MOH treatment. Results The study population was constituted by 193 patients out of 212. The average age of patients was 42 ± 14 years, of whom 66.32% were women. MOH rate was 35.75%. The associated factors were: early age (p=0.003), concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol (p=0.0001) as well as self-medication (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|